Heme oxygenase metabolites inhibit tubuloglomerular feedback in vivo

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 300, Issue 4, 2011, Pages

  Wang, Hong ^a   Garvin, Jeffrey L ^a   D'Ambrosio, Martin A ^a   Falck, John R ^b   Leung, Pablo ^a   Liu, Ruisheng ^c   Ren, Yilin ^a   Carretero, Oscar A ^a  

^a HENRY FORD HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Afferent arteriole; Biliverdin; Carbon monoxide; Stop flow pressure

Indexed keywords

6 ANILINO 5,8 QUINOLINEQUINONE; BILIVERDIN; CARBON MONOXIDE; GUANYLATE CYCLASE INHIBITOR; HEME OXYGENASE; HEME OXYGENASE 1; HEME OXYGENASE 2; HEME OXYGENASE INHIBITOR; STANNSOPORFIN; SUPEROXIDE DISMUTASE; TEMPOL;

ANASTOMOSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEEDBACK SYSTEM; HYPOTHESIS; IN VITRO STUDY; KIDNEY FUNCTION; KIDNEY TUBULOGLOMERULAR FEEDBACK; LASER CAPTURE MICRODISSECTION; MACULA DENSA; MALE; NEPHRON; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION;

AMINOQUINOLINES; ANIMALS; BILIVERDINE; CARBON MONOXIDE; CYCLIC N-OXIDES; ENZYME INHIBITORS; FEEDBACK; GUANYLATE CYCLASE; HEME OXYGENASE (DECYCLIZING); KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; METALLOPORPHYRINS; ORGANOMETALLIC COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SPIN LABELS; SUPEROXIDES;

EID: 79955066278     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01118.2010     Document Type: Article

References (42)

1. Abraham NG, Kappas A. Heme oxygenase and the cardiovascular-renal system. Free Radic Biol Med 39: 1-25, 2005.
2. Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60: 79-127, 2008.
3. Abraham NG, Lin JH, Laniado Schwartzman M, Levere RD, Shiba-hara S. The physiological significance of heme oxygenase. Int J Biochem 20: 543-558, 1988.
4. Aizawa T, Ishizaka N, Taguchi J, Nagai R, Mori I, Tang SS, Ingel-finger JR, Ohno M. Heme-oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats. Possible role in renoprotection. Hypertension 35: 800-806, 2000.
5. Alonso JR, Cardellach F, Lopez S, Casademont J, Miro O. Carbon monoxide specifically inhibits cytochrome c oxidase of human mitochon-drial respiratory chain. Pharmacol Toxicol 93: 142-146, 2003.
6. Baranano DE, Rao M, Ferris CD, Snyder SH. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 99: 16093-16098, 2002.
7. Botros FT, Prieto-Carrasquero MC, Martin VL, Navar LG. Heme oxygenase induction attenuates afferent arteriolar autoregulatory responses. Am J Physiol Renal Physiol 295: F904-F911, 2008.
8. da Silva JL, Zand BA, Yang LM, Sabaawy HE, Lianos E, Abraham NG. Heme oxygenase isoform-specific expression and distribution in the rat kidney. Kidney Int 59: 1448-1457, 2001.
9. Djousse L, Levy D, Cupples LA, Evans JC, D'Agostino RB, Ellison RC. Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol 87: 1196-1200, 2001.
10. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA, Liotta LA. Laser capture microdissection. Science 274: 998-1001, 1996.
11. Exner M, Minar E, Wagner O, Schillinger M. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med 37: 1097-1104, 2004.
12. Hu Y, Ma N, Yang M, Semba R. Expression and distribution of heme oxygenase-2 mRNA and protein in rat kidney. J Histochem Cytochem 46: 249-256, 1998.
13. Inoguchi T, Sasaki S, Kobayashi K, Takayanagi R, Yamada T. Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes. JAMA 298: 1398-1400, 2007.
14. Johnson RA, Lavesa M, Askari B, Abraham NG, Nasjletti A. A heme oxygenase product, presumably carbon monoxide, mediates a vasodepres-sor function in rats. Hypertension 25: 166-169, 1995.
15. Kelsen S, Patel BJ, Parker LB, Vera T, Rimoldi JM, Gadepalli RS, Drummond HA, Stec DE. Heme oxygenase attenuates angiotensin II-mediated superoxide production in cultured mouse thick ascending loop of Henle cells. Am J Physiol Renal Physiol 295: F1158-F1165, 2008.
16. Lanone S, Bloc S, Foresti R, Almolki A, Taille C, Callebert J, Conti M, Goven D, Aubier M, Dureuil B, El-Benna J, Motterlini R, Boczkowski J. Bilirubin decreases NOS2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats. FASEB J 19: 1890-1892, 2005.
17. Leblanc RM, Navar LG, Botros FT. Bilirubin exerts renoprotective effects in angiotensin II-hypertension. Am J Med Sci 340: 144-146, 2010.
18. Li N, Yi F, Dos Santos EA, Donley DK, Li PL. Role of renal medullary heme oxygenase in the regulation of pressure natriuresis and arterial blood pressure. Hypertension 49: 148-154, 2007.
19. Loutzenhiser R, Griffin K, Williamson G, Bidani A. Renal autoregu-lation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms. Am J Physiol Regul Integr Comp Physiol 290: R1153-R1167, 2006.
20. Meffert MK, Haley JE, Schuman EM, Schulman H, Madison DV. Inhibition of hippocampal heme oxygenase, nitric oxide synthase, and long-term potentiation by metalloporphyrins. Neuron 13: 1225-1233, 1994.
21. Morita T, Perrella MA, Lee ME, Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA 92: 1475-1479, 1995.
22. Motterlini R. Carbon monoxide-releasing molecules (CO-RMs): vasodi-latory, anti-ischaemic and anti-inflammatory activities. Biochem Soc Trans 35: 1142-1146, 2007.
23. Nantel F, Meadows E, Denis D, Connolly B, Metters KM, Giaid A. Immunolocalization of cyclooxygenase-2 in the macula densa of human elderly. FEBS Lett 457: 475-477, 1999.
24. Navar LG, Inscho EW, Majid DS, Imig JD, Harrison-Bernard LM, Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev 76: 425-536, 1996.
25. O'Donaughy TL, Walker BR. Renal vasodilatory influence of endogenous carbon monoxide in chronically hypoxic rats. Am J Physiol Heart Circ Physiol 279: H2908-H2915, 2000.
26. Pflueger A, Croatt AJ, Peterson TE, Smith LA, d'Uscio LV, Katusic ZS, Nath KA. The hyperbilirubinemic Gunn rat is resistant to the pressor effects of angiotensin II. Am J Physiol Renal Physiol 288: F552-F558, 2005.
27. Ren Y, Arima S, Carretero OA, Ito S. Possible role of adenosine in macula densa control of glomerular hemodynamics. Kidney Int 61: 169-176, 2002.
28. Ren Y, Carretero OA, Garvin JL. Mechanism by which superoxide potentiates tubuloglomerular feedback. Hypertension 39: 624-628, 2002.
29. Ren Y, D'Ambrosio MA, Wang H, Liu R, Garvin JL, Carretero OA. Heme oxygenase metabolites inhibit tubuloglomerular feedback (TGF). Am J Physiol Renal Physiol 295: F1207-F1212, 2008.
30. Ren Y, Garvin JL, Carretero OA. Role of macula densa nitric oxide and cGMP in the regulation of tubuloglomerular feedback. Kidney Int 58: 2053-2060, 2000.
31. Ren Y, Garvin JL, Liu R, Carretero OA. Crosstalk between the connecting tubule and the afferent arteriole regulates renal microcircula-tion. Kidney Int 71: 1116-1121, 2007.
32. Robertson P Jr, Fridovich I. A reaction of the superoxide radical with tetrapyrroles. Arch Biochem Biophys 213: 353-357, 1982.
33. Ryan MJ, Jernigan NL, Drummond HA, McLemore GR Jr, Rimoldi JM, Poreddy SR, Gadepalli RS, Stec DE. Renal vascular responses to CORM-A1 in the mouse. Pharmacol Res 54: 24-29, 2006.
34. Schnermann J, Briggs J. Concentration-dependent sodium chloride transport as the signal in feedback control of glomerular filtration rate. Kidney Int 22, Suppl 12: S82-S89, 1982.
35. Schnermann J, Traynor T, Yang T, Arend L, Huang YG, Smart A, Briggs JP. Tubuloglomerular feedback: new concepts and developments. Kidney Int 54, Suppl 67: S40-S45, 1998.
36. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 235: 1043-1046, 1987.
37. Vitek L, Jirsa M, Brodanova M, Kalab M, Marecek Z, Danzig V, Novotny L, Kotal P. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 160: 449-456, 2002.
38. Wang H, Carretero OA, Garvin JL. Nitric oxide produced by THAL nitric oxide synthase inhibits TGF. Hypertension 39: 662-666, 2002.
39. Wu L, Cao K, Lu Y, Wang R. Different mechanisms underlying the stimulation of K(Ca) channels by nitric oxide and carbon monoxide. J Clin Invest 110: 691-700, 2002.
40. Wu L, Wang R. Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev 57: 585-630, 2005.
41. Zhang R, Harding P, Garvin JL, Juncos R, Peterson E, Juncos LA, Liu R. Isoforms and functions of NAD(P)H oxidase at the macula densa. Hypertension 53: 556-563, 2009.
42. Zou AP, Billington H, Su N, Cowley AW. Expression and actions of heme oxygenase in the renal medulla of rats. Hypertension 35: 342-347, 2000.